Head to Head Review: Biotricity (BTCY) and Its Peers

Biotricity (OTCMKTS:BTCYGet Rating) is one of 85 public companies in the “Electric services” industry, but how does it contrast to its peers? We will compare Biotricity to related companies based on the strength of its dividends, analyst recommendations, risk, valuation, profitability, earnings and institutional ownership.

Analyst Ratings

This is a breakdown of recent recommendations for Biotricity and its peers, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Biotricity 0 1 2 0 2.67
Biotricity Competitors 547 3323 3115 60 2.38

Biotricity presently has a consensus price target of $5.67, suggesting a potential upside of 364.48%. As a group, “Electric services” companies have a potential upside of 3.15%. Given Biotricity’s stronger consensus rating and higher probable upside, analysts clearly believe Biotricity is more favorable than its peers.

Insider and Institutional Ownership

5.5% of Biotricity shares are owned by institutional investors. Comparatively, 66.9% of shares of all “Electric services” companies are owned by institutional investors. 2.4% of shares of all “Electric services” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Volatility and Risk

Biotricity has a beta of 1.7, suggesting that its share price is 70% more volatile than the S&P 500. Comparatively, Biotricity’s peers have a beta of -1.16, suggesting that their average share price is 216% less volatile than the S&P 500.

Valuation and Earnings

This table compares Biotricity and its peers revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Biotricity $7.70 million N/A -1.79
Biotricity Competitors $9.22 billion $453.28 million 5.19

Biotricity’s peers have higher revenue and earnings than Biotricity. Biotricity is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.


This table compares Biotricity and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Biotricity N/A N/A N/A
Biotricity Competitors -5.93% 6.90% 2.15%


Biotricity peers beat Biotricity on 7 of the 12 factors compared.

Biotricity Company Profile

(Get Rating)

Biotricity, Inc., medical technology company, provides biometric data monitoring solutions primarily in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated electrocardiogram (ECG) device and software solution. The company is based in Redwood City, California.

Receive News & Ratings for Biotricity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biotricity and related companies with MarketBeat.com's FREE daily email newsletter.